Back to
LMR Partners LLP
NGEN1 quarters
Position history for
LMR Partners LLP's holdings in NERVGEN PHARMA CORP
LMR Partners LLP holds 600,000 shares of NGEN (NERVGEN PHARMA CORP), worth $1.2M as of 2026-Q2. This is a new position. NGEN represents 0.0% of LMR Partners LLP's portfolio.
Current Value
$1.2M
Current Shares
600,000
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NGEN: MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA